|
Valoración de DCF de Privi Specialty Chemicals Limited (Priviscl.NS)
IN | Basic Materials | Chemicals - Specialty | NSE
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Privi Speciality Chemicals Limited (PRIVISCL.NS) Bundle
Ya sea que sea un inversionista o analista, esta calculadora DCF (privisclns) es su recurso para una valoración precisa. Equipado con datos reales de Privi Specialty Chemicals Limited, puede ajustar las previsiones y observar los efectos en tiempo real.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16,113.5 | 12,681.0 | 14,023.8 | 16,078.2 | 17,522.3 | 18,088.2 | 18,672.4 | 19,275.4 | 19,897.9 | 20,540.6 |
| Revenue Growth, % | 0 | -21.3 | 10.59 | 14.65 | 8.98 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 |
| EBITDA | 2,808.8 | 2,524.9 | 2,327.2 | 2,090.9 | 3,540.6 | 3,152.7 | 3,254.5 | 3,359.6 | 3,468.1 | 3,580.1 |
| EBITDA, % | 17.43 | 19.91 | 16.59 | 13 | 20.21 | 17.43 | 17.43 | 17.43 | 17.43 | 17.43 |
| Depreciation | 567.7 | 710.0 | 746.6 | 1,084.9 | 1,234.1 | 1,021.5 | 1,054.5 | 1,088.5 | 1,123.7 | 1,160.0 |
| Depreciation, % | 3.52 | 5.6 | 5.32 | 6.75 | 7.04 | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 |
| EBIT | 2,241.1 | 1,814.9 | 1,580.6 | 1,006.0 | 2,306.4 | 2,131.2 | 2,200.0 | 2,271.0 | 2,344.4 | 2,420.1 |
| EBIT, % | 13.91 | 14.31 | 11.27 | 6.26 | 13.16 | 11.78 | 11.78 | 11.78 | 11.78 | 11.78 |
| Total Cash | 858.0 | 154.5 | 445.2 | 318.2 | 635.5 | 554.3 | 572.2 | 590.7 | 609.8 | 629.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2,650.1 | 3,005.4 | 3,501.7 | 2,955.9 | 3,475.0 | 3,738.2 | 3,858.9 | 3,983.5 | 4,112.2 | 4,245.0 |
| Account Receivables, % | 16.45 | 23.7 | 24.97 | 18.38 | 19.83 | 20.67 | 20.67 | 20.67 | 20.67 | 20.67 |
| Inventories | 3,664.3 | 3,425.3 | 6,163.2 | 7,993.8 | 6,827.2 | 6,597.9 | 6,811.0 | 7,030.9 | 7,258.0 | 7,492.4 |
| Inventories, % | 22.74 | 27.01 | 43.95 | 49.72 | 38.96 | 36.48 | 36.48 | 36.48 | 36.48 | 36.48 |
| Accounts Payable | 1,497.2 | 1,673.9 | 3,058.0 | 2,939.2 | 2,825.1 | 2,847.2 | 2,939.1 | 3,034.0 | 3,132.0 | 3,233.2 |
| Accounts Payable, % | 9.29 | 13.2 | 21.81 | 18.28 | 16.12 | 15.74 | 15.74 | 15.74 | 15.74 | 15.74 |
| Capital Expenditure | -2,106.6 | -2,427.9 | -3,086.3 | -1,396.9 | -1,505.1 | -2,586.8 | -2,670.3 | -2,756.6 | -2,845.6 | -2,937.5 |
| Capital Expenditure, % | -13.07 | -19.15 | -22.01 | -8.69 | -8.59 | -14.3 | -14.3 | -14.3 | -14.3 | -14.3 |
| Tax Rate, % | 26.94 | 26.94 | 26.94 | 26.94 | 26.94 | 26.94 | 26.94 | 26.94 | 26.94 | 26.94 |
| EBITAT | 1,415.1 | 1,341.0 | 1,159.4 | 719.9 | 1,685.0 | 1,513.1 | 1,562.0 | 1,612.4 | 1,664.5 | 1,718.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -4,940.9 | -316.5 | -3,030.5 | -995.7 | 1,947.4 | -64.0 | -295.7 | -305.2 | -315.1 | -325.3 |
| WACC, % | 5.45 | 5.61 | 5.6 | 5.57 | 5.6 | 5.57 | 5.57 | 5.57 | 5.57 | 5.57 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1,087.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -332 | |||||||||
| Terminal Value | -9,304 | |||||||||
| Present Terminal Value | -7,096 | |||||||||
| Enterprise Value | -8,184 | |||||||||
| Net Debt | 9,842 | |||||||||
| Equity Value | -18,026 | |||||||||
| Diluted Shares Outstanding, MM | 39 | |||||||||
| Equity Value Per Share | -461.45 |
What You Will Receive
- Customizable Excel Template: A fully adaptable Excel-based DCF Calculator featuring pre-filled financial data for PRIVISCLNS (PRIVISCLNS).
- Accurate Market Data: Historical figures alongside forward-looking projections (highlighted in the yellow cells).
- Flexible Forecasting: Adjust key assumptions such as revenue growth, EBITDA percentage, and WACC to suit your strategy.
- Instant Calculations: Quickly observe how your inputs affect the valuation of Privi Speciality Chemicals Limited (PRIVISCLNS).
- Professional Resource: Designed for investors, CFOs, consultants, and analysts in the financial sector.
- Intuitive Layout: Organized for simplicity and straightforward navigation, complete with step-by-step guidance.
Key Features
- Comprehensive PRIVISCLNS Data: Pre-loaded with Privi Speciality Chemicals Limited’s historical financial information and future growth projections.
- Fully Customizable Inputs: Tailor revenue growth, profit margins, WACC, tax rates, and capital expenditures to suit your analysis.
- Dynamic Valuation Model: Instant updates to Net Present Value (NPV) and intrinsic value reflecting your customized inputs.
- Scenario Analysis: Develop multiple forecasting scenarios to explore various valuation outcomes.
- User-Friendly Interface: Intuitive, organized, and suitable for both professionals and novice users.
How It Operates
- Step 1: Download the Excel spreadsheet.
- Step 2: Examine Privi Speciality Chemicals Limited’s (PRIVISCLNS) pre-populated financial data and projections.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (cells highlighted for your convenience).
- Step 4: Observe the DCF model refresh in real-time as you modify your assumptions.
- Step 5: Evaluate the results and apply the findings for your investment strategies.
Why Choose this Calculator for Privi Speciality Chemicals Limited (PRIVISCLNS)?
- Designed for Experts: A sophisticated tool trusted by analysts, financial officers, and consultants.
- Up-to-Date Data: Privi Speciality Chemicals' actual and projected financial information is included for precision.
- Scenario Simulation: Easily test various forecasts and assumptions to assess outcomes.
- Comprehensive Outputs: Instantly computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the process.
Who Can Benefit from Privi Speciality Chemicals Limited (PRIVISCLNS)?
- Investors: Enhance your investment strategy with a robust valuation tool tailored for the chemical industry.
- Financial Analysts: Streamline your workflow with a comprehensive DCF model designed for easy modifications.
- Consultants: Effortlessly customize the template for impactful client presentations and reports.
- Chemistry and Finance Enthusiasts: Expand your knowledge of valuation methods through practical, industry-specific examples.
- Educators and Students: Utilize this resource as an effective learning aid in finance and chemistry courses.
Contents of the Template
- Pre-Filled DCF Model: Financial data for Privi Speciality Chemicals Limited (PRIVISCLNS) preloaded for immediate application.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Analyze Privi's profitability, leverage, and efficiency metrics.
- Editable Inputs: Adjust assumptions such as growth rates, margins, and capital expenditures to suit your specific scenarios.
- Financial Statements: Access annual and quarterly reports for thorough analysis.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.